LIGAND PHARMACEUTICALS INC (LGND) › Total AssetsLIGAND PHARMACEUTICALS INC (LGND) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $75.56M2011: $120.58M2012: $104.26M2013: $104.71M2014: $258.03M2015: $503.06M2016: $601.59M2017: $671.02M2018: $1.26B2019: $1.49B2020: $1.36B2021: $1.30B2022: $762.67M2023: $787.22M2024: $941.77M2025: $1.56B$1.56B2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$1.56B+65.7%2024$941.77M+19.6%2023$787.22M+3.2%2022$762.67M-41.2%2021$1.30B-4.7%2020$1.36B-8.9%2019$1.49B+18.6%2018$1.26B+87.9%2017$671.02M+11.5%2016$601.59M+19.6%2015$503.06M+95.0%2014$258.03M+146.4%2013$104.71M+0.4%2012$104.26M-13.5%2011$120.58M+59.6%2010$75.56M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share